Filtros de búsqueda

Lista de obras de Fernando Lanas

Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

artículo científico

Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial

artículo científico publicado en 2013

Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

artículo científico publicado en 2015

Cardiovascular involvement in rheumatic diseases (author's transl)

artículo científico publicado el 1 de mayo de 1978

Clinical and hemodynamic evaluation of isosorbide dinitrate therapy in heart failure (author's transl)

artículo científico publicado el 1 de agosto de 1979

Digoxin is effective in th treatment of patients with heart failure and sinus rhythm

artículo científico publicado el 1 de octubre de 1994

Dronedarone in High-Risk Permanent Atrial Fibrillation

artículo científico publicado en 2011

Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial

artículo científico publicado en 2015

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.

artículo científico publicado en 2013

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial

artículo científico publicado en 2012

Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study

artículo científico publicado en 2016

History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial.

artículo científico publicado en 2016

Ideal Cardiovascular Health in the southern cone of Latin America.

artículo científico publicado en 2018

Latin American Clinical Epidemiology Network Series - Paper 2: Apixaban was cost-effective vs. acenocoumarol in patients with nonvalvular atrial fibrillation with moderate to severe risk of embolism in Chile

artículo científico publicado en 2016

Latin American Clinical Epidemiology Network Series - Paper 7: Central obesity measurements better identified risk factors for coronary heart disease risk in the Chilean National Health Survey (2009-2010).

artículo científico publicado en 2016

Latin American Clinical Epidemiology Network Series - Paper 8: Ticagrelor was cost-effective vs. clopidogrel in acute coronary syndrome in Chile.

artículo científico publicado en 2016

Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures

artículo científico publicado en 2014

Marfan's syndrome (author's transl)

artículo científico publicado el 1 de junio de 1978

Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study

artículo científico publicado en 2013

Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial

scientific article published on 02 May 2019

Pathology of excised cardiac valves: correlation with clinical findings (author's transl)

artículo científico publicado el 1 de mayo de 1979

Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial

artículo científico publicado en 2016

Postural hypotension in diabetic patients (author's transl)

artículo científico publicado el 1 de marzo de 1977

Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study

artículo científico publicado en 2018

Prevalence of cardiovascular risk factors in Temuco City

artículo científico publicado el 1 de marzo de 1991

Prevalence of risk factors to cardiovascular disease in group of Chilean employees

artículo científico publicado el 1 de febrero de 2003

Prevalence, Distributions and Determinants of Obesity and Central Obesity in the Southern Cone of America

artículo científico publicado en 2016

Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial

artículo científico publicado en 2017

Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial

scientific article published on 30 December 2019

Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".

artículo científico publicado en 2014

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.

artículo científico publicado en 2017

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2017

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

artículo científico publicado en 2019

Treatment of advanced heart failure with hydralazine and isosorbide dinitrate (author's transl)

artículo científico publicado el 1 de octubre de 1979

Variations in knowledge, awareness and treatment of hypertension and stroke risk by country income level

artículo científico publicado en 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda